Cargando…
Clinical trials, adaptability and the COVID-19 pandemic
Despite the impact of the COVD-19 pandemic and public health crisis on health care delivery, the GOG-Foundation has continued to prioritize the delivery of novel and state-of-the-science treatment options to patients via clinical trials.
Autores principales: | Eskander, Ramez N., Pothuri, Bhavana, Randall, Leslie, O'Malley, David, Slomovitz, Brian, Moore, Kathleen, Coleman, Robert, Herzog, Thomas, Monk, Bradley J., Copeland, Larry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723439/ https://www.ncbi.nlm.nih.gov/pubmed/33319009 http://dx.doi.org/10.1016/j.gore.2020.100680 |
Ejemplares similares
-
Overcoming the challenges of drug development in platinum-resistant ovarian cancer
por: Eskander, Ramez N., et al.
Publicado: (2023) -
COVID-19 and ovarian cancer: Exploring alternatives to intravenous (IV) therapies
por: Monk, Bradley J., et al.
Publicado: (2020) -
Bevacizumab in the treatment of ovarian cancer
por: Eskander, Ramez N, et al.
Publicado: (2011) -
A revised model for the role of GacS/GacA in regulating type III secretion by Pseudomonas syringae pv. tomato DC3000
por: O’Malley, Megan R., et al.
Publicado: (2019) -
Today's virtual teams: Adapting lessons learned to the pandemic context
por: Feitosa, Jennifer, et al.
Publicado: (2021)